Background: Hypertensive disorder of pregnancy (HDP) is a group of diseases in which pregnancy and elevated blood pressure coexist. There is still a lack of reliable clinical tools to predict the incidence of HDP. The purpose of this study was to establish and validate a nomogram prediction model for assessing the risk of HDP in pregnant women based on laboratory indicators and HDP risk factors. Method: A total of 307 pregnant women who were hospitalized in the obstetrics and gynecology department of our hospital were included in this study, and were randomly divided into a training cohort and validation cohort at a ratio of 7:3. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for the development of HDP on laboratory indicators as well as risk factors for HDP in the training cohort of patients. The results of the multivariate regression model were visualized by forest plots. A nomogram was constructed based on the results of multivariate logistic regression to predict the risk of HDP in pregnant women. The validity of the risk prediction model was evaluated by the area under the receiver operating characteristic curve (AUC), the consistency index (C-index), the calibration curve and the decision curve analysis (DCA). Results: BMI ≥ 25 Kg/m2, total cholesterol in early pregnancy, uric acid and proteinuria in late pregnancy were independent risk factors for HDP. The AUC and C-index of the nomogram constructed by the above four factors were both 0.848. The calibration curve is closely fitted with the ideal diagonal, showing a good consistency between the nomogram prediction and the actual observation of HDP. The DCA has demonstrated the great clinical utility of nomogram. Internal verification proves the reliability of the predicted nomograms. Conclusion: The BTUP nomogram model based on laboratory indicators and risk factors proposed in this study showed good predictive value for the risk assessment of HDP. It is expected to provide evidence for clinical prediction of the risk of HDP in pregnant women.
References
[1]
Umesawa, M. and Kobashi, G. (2016) Epidemiology of Hypertensive Disorders in Pregnancy: Prevalence, Risk Factors, Predictors and Prognosis. Hypertension Research, 40, 213-220. https://doi.org/10.1038/hr.2016.126
[2]
Lawn, J.E., Blencowe, H., Waiswa, P., Amouzou, A., Mathers, C., Hogan, D., et al. (2016) Stillbirths: Rates, Risk Factors, and Acceleration towards 2030. The Lancet, 387, 587-603. https://doi.org/10.1016/s0140-6736(15)00837-5
[3]
Kumar, N. and Singh, A.K. (2019) Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study. Current Hypertension Reviews, 15, 154-160. https://doi.org/10.2174/1573402114666181112141953
[4]
von Dadelszen, P., Payne, B., Li, J., Ansermino, J.M., Pipkin, F.B., Côté, A., et al. (2011) Prediction of Adverse Maternal Outcomes in Pre-Eclampsia: Development and Validation of the Fullpiers Model. The Lancet, 377, 219-227. https://doi.org/10.1016/s0140-6736(10)61351-7
[5]
Townsend, R., Khalil, A., Premakumar, Y., Allotey, J., Snell, K.I.E., Chan, C., et al. (2019) Prediction of Pre‐Eclampsia: Review of Reviews. Ultrasound in Obstetrics & Gynecology, 54, 16-27. https://doi.org/10.1002/uog.20117
[6]
Al‐Rubaie, Z., Askie, L., Ray, J., Hudson, H. and Lord, S. (2016) The Performance of Risk Prediction Models for Pre‐Eclampsia Using Routinely Collected Maternal Characteristics and Comparison with Models That Include Specialised Tests and with Clinical Guideline Decision Rules: A Systematic Review. BJOG: An International Journal of Obstetrics & Gynaecology, 123, 1441-1452. https://doi.org/10.1111/1471-0528.14029
[7]
Murtoniemi, K., Villa, P.M., Matomäki, J., Keikkala, E., Vuorela, P., Hämäläinen, E., et al. (2018) Prediction of Pre-Eclampsia and Its Subtypes in High-Risk Cohort: Hyperglycosylated Human Chorionic Gonadotropin in Multivariate Models. BMC Pregnancy and Childbirth, 18, Article No. 279. https://doi.org/10.1186/s12884-018-1908-9
[8]
Brunelli, V. and Prefumo, F. (2015) Quality of First Trimester Risk Prediction Models for Pre‐Eclampsia: A Systematic Review. BJOG: An International Journal of Obstetrics & Gynaecology, 122, 904-914. https://doi.org/10.1111/1471-0528.13334
[9]
Yin, F., Hou, C., Wang, S., Wang, X. and Yang, Z. (2023) A Nomogram for Predicting Overall Survival in Patients with Parathyroid Cancer: A Novel Web-Based Calculator. Asian Journal of Surgery, 46, 4169-4177. https://doi.org/10.1016/j.asjsur.2022.10.012
[10]
Balachandran, V.P., Gonen, M., Smith, J.J. and DeMatteo, R.P. (2015) Nomograms in Oncology: More Than Meets the Eye. The Lancet Oncology, 16, e173-e180. https://doi.org/10.1016/s1470-2045(14)71116-7
[11]
Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association (2020) Diagnosis and Treatment of Hypertension and Pre-Eclampsia in Pregnancy: A Clinical Practice Guideline in China. Chinese Journal of Obstetrics and Gynecology, 55, 227-238.
[12]
Khedagi, A.M. and Bello, N.A. (2021) Hypertensive Disorders of Pregnancy. Cardiology Clinics, 39, 77-90. https://doi.org/10.1016/j.ccl.2020.09.005
[13]
Jian, S., Zhang, L., Zhang, X., Liu, Y., Yao, M., Xiao, J., et al. (2019) A Survey on the Prevalence and Risk Factors of Hypertensive Syndrome of Pregnancy in Pregnant Women Aged 17-39 Years in Rural Areas of Tongren District, Guizhou Province. Modern Preventive Medicine, 46, 3323-3327.
[14]
Ma, R., Lu, Y., Gu, Q., et al. (2020) Epidemiologic Survey of Hypertensive Syndrome of Pregnancy in Ethnic Minority Areas of Gansu Province and Its Impact on Maternal and Infant Outcomes. Chinese Preventive Medicine, 21, 1280-1285.
[15]
Poorolajal, J. and Jenabi, E. (2016) The Association between Body Mass Index and Preeclampsia: A Meta-Analysis. The Journal of Maternal-Fetal & Neonatal Medicine, 29, 3670-3676. https://doi.org/10.3109/14767058.2016.1140738
[16]
Sun, Y., Shen, Z., Zhan, Y., Wang, Y., Ma, S., Zhang, S., et al. (2020) Effects of Pre-Pregnancy Body Mass Index and Gestational Weight Gain on Maternal and Infant Complications. BMC Pregnancy and Childbirth, 20, Article No. 390. https://doi.org/10.1186/s12884-020-03071-y
[17]
Wang, L., Li, W., Li, W., Zhang, S., Liu, X. and Leng, J. (2023) Effect of Overweight/Obesity and High Normal Blood Pressure in Early Pregnancy on Blood Pressure Levels after 20 Weeks’ Gestation. Chinese Journal of Hypertension, 31, 1056-1063.
[18]
Zhao, H., Pan, S., Liu, Y., Zhen, W. and Li, D. (2019) A Study of the Effect of Pre-pregnancy Over-Weight/Obesity on Maternal and Fetal Outcome and Labor and Delivery. Progress in Modern Obstetrics and Gynecology, 28, 416-419.
[19]
Schubert, J., Timmesfeld, N., Noever, K., Behnam, S., Vinturache, A. and Arabin, B. (2022) Impact of Maternal Body Mass Index and Gestational Weight Gain on Maternal and Neonatal Outcomes in Twin Pregnancies. Acta Obstetricia et Gynecologica Scandinavica, 102, 181-189. https://doi.org/10.1111/aogs.14485
[20]
Ehrenthal, D.B., Jurkovitz, C., Hoffman, M., Jiang, X. and Weintraub, W.S. (2011) Prepregnancy Body Mass Index as an Independent Risk Factor for Pregnancy-Induced Hypertension. Journal of Women’s Health, 20, 67-72. https://doi.org/10.1089/jwh.2010.1970
[21]
Gasse, C., Boutin, A., Demers, S., Chaillet, N. and Bujold, E. (2017) Body Mass Index and the Risk of Hypertensive Disorders of Pregnancy: The Great Obstetrical Syndromes (GOS) Study. The Journal of Maternal-Fetal & Neonatal Medicine, 32, 1063-1068. https://doi.org/10.1080/14767058.2017.1399117
[22]
Ma, Z., Zhuang, B., Xi, J., Chu, L., Zhang, Y., Liu, P., et al. (2023) Correlation of pre-Pregnancy Body Mass Index and Rate of Weight Gain during Pregnancy with Hypertensive Disorders of Pregnancy. Maternal & Child Health Care of China, 38, 201-204.
[23]
Rao, S.J., Martin, S.S., Lawson, S.M., Hailu, T., Davis, D.M., Nasir, K., et al. (2022) Evaluating the Role of Statins in Prevention of Preeclampsia: Deeper Insights into Maternal Cardiometabolic Changes. Journal of Clinical Lipidology, 16, 403-416. https://doi.org/10.1016/j.jacl.2022.04.007
[24]
Salma, U. (2022) Relationship of Serum Lipid Profiles in Preeclampsia and Normal Pregnancy, Bangladesh. African Health Sciences, 22, 475-479. https://doi.org/10.4314/ahs.v22i2.55
[25]
Areda, B.G., Gizaw, S.T., Berdida, D.H. and Kebalo, A.H. (2022) Evaluation of Serum Lipid Profiles, Uric Acid, and High Sensitivity C‐Reactive Protein Levels between Pregnancy‐Induced Hypertension and Normotensive Pregnant Women Attending Ambo University Referral Hospital, Ambo, Ethiopia, 2020: A Case‐Control Study. Health Science Reports, 5, e806. https://doi.org/10.1002/hsr2.806
[26]
Al-Kuraishy, H., Al-Maiahy, T. and Al-Gareeb, A. (2021) Role of Dyslipidemia in the Development of Early-Onset Preeclampsia. Journal of Advanced Pharmaceutical Technology & Research, 12, 73-78. https://doi.org/10.4103/japtr.japtr_104_20
[27]
Mou, A.D., Barman, Z., Hasan, M., Miah, R., Hafsa, J.M., Das Trisha, A., et al. (2021) Prevalence of Preeclampsia and the Associated Risk Factors among Pregnant Women in Bangladesh. Scientific Reports, 11, Article No. 21339. https://doi.org/10.1038/s41598-021-00839-w
[28]
Wang, Y., Shi, D. and Chen, L. (2018) Lipid Profile and Cytokines in Hypertension of Pregnancy: A Comparison of Preeclampsia Therapies. The Journal of Clinical Hypertension, 20, 394-399. https://doi.org/10.1111/jch.13161
[29]
Shen, H., Liu, X., Chen, Y., HE, B. and Cheng, W. (2016) Associations of Lipid Levels during Gestation with Hypertensive Disorders of Pregnancy and Gestational Diabetes Mellitus: A Prospective Longitudinal Cohort Study. BMJ Open, 6, e013509. https://doi.org/10.1136/bmjopen-2016-013509
[30]
Zhang, Y., Lan, X., Cai, C., Li, R., Gao, Y., Yang, L., et al. (2019) Associations between Maternal Lipid Profiles and Pregnancy Complications: A Prospective Population-Based Study. American Journal of Perinatology, 38, 834-840. https://doi.org/10.1055/s-0039-3402724
[31]
Hurtubise, J., McLellan, K., Durr, K., Onasanya, O., Nwabuko, D. and Ndisang, J.F. (2016) The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis. Current Atherosclerosis Reports, 18, Article No. 82. https://doi.org/10.1007/s11883-016-0632-z
[32]
Adank, M.C., Benschop, L., Peterbroers, K.R., Smak Gregoor, A.M., Kors, A.W., Mulder, M.T., et al. (2019) Is Maternal Lipid Profile in Early Pregnancy Associated with Pregnancy Complications and Blood Pressure in Pregnancy and Long Term Postpartum? American Journal of Obstetrics and Gynecology, 221, 150.e1-150.e13. https://doi.org/10.1016/j.ajog.2019.03.025
[33]
Masoura, S., Makedou, K., Theodoridis, T., Kourtis, A., Zepiridis, L. and Athanasiadis, A. (2015) The Involvement of Uric Acid in the Pathogenesis of Preeclampsia. Current Hypertension Reviews, 11, 110-115. https://doi.org/10.2174/1573402111666150529130703
[34]
Colmenares-Mejia, C.C., Quintero-Lesmes, D.C., Bautista-Niño, P.K., Guío, E., Paez, M.C., Beltrán, M., et al. (2023) Uric Acid and Risk of Pre-Eclampsia: Results from a Large Case—Control Study and Meta-Analysis of Prospective Studies. Scientific Reports, 13, Article No. 3018. https://doi.org/10.1038/s41598-023-29651-4
[35]
Li, B., Lin, L., Yang, H., Zhu, Y., Wei, Y., Li, X., et al. (2018) The Value of the 24-H Proteinuria in Evaluating the Severity of Preeclampsia and Predicting Its Adverse Maternal Outcomes. Hypertension in Pregnancy, 37, 118-125. https://doi.org/10.1080/10641955.2018.1487564
[36]
Hu, M., Shi, J. and Lu, W. (2022) Association between Proteinuria and Adverse Pregnancy Outcomes: A Retrospective Cohort Study. Journal of Obstetrics and Gynaecology, 43, Article 2126299. https://doi.org/10.1080/01443615.2022.2126299
[37]
Wang, X.X., Liu, J.T., Gao, J.S., Song, Y.J. and Song, Y.N. (2022) Value of Proteinuria in Assessing the Severity of Pre-Eclampsia and Its Maternal and Neonatal Outcomes. Chinese Journal of Obstetrics and Gynecology, 57, 325-331.
[38]
Lei, T., Qiu, T., Liao, W., Li, K., Lai, X., Huang, H., et al. (2021) Proteinuria May Be an Indicator of Adverse Pregnancy Outcomes in Patients with Preeclampsia: A Retrospective Study. Reproductive Biology and Endocrinology, 19, Article No. 71. https://doi.org/10.1186/s12958-021-00751-y
[39]
Shinar, S., Asher-Landsberg, J., Schwartz, A., Ram-Weiner, M., Kupferminc, M.J. and Many, A. (2015) Isolated Proteinuria Is a Risk Factor for Pre-Eclampsia: A Retrospective Analysis of the Maternal and Neonatal Outcomes in Women Presenting with Isolated Gestational Proteinuria. Journal of Perinatology, 36, 25-29. https://doi.org/10.1038/jp.2015.138
[40]
Morikawa, M., Mayama, M., Noshiro, K., Saito, Y., Nakagawa-Akabane, K., Umazume, T., et al. (2021) Earlier Onset of Proteinuria or Hypertension Is a Predictor of Progression from Gestational Hypertension or Gestational Proteinuria to Preeclampsia. Scientific Reports, 11, Article No. 12708. https://doi.org/10.1038/s41598-021-92189-w
[41]
Chung, W.H. and To, W.W.K. (2018) Outcome of Pregnancy with New Onset Proteinuria and Progression to Pre-Eclampsia: A Retrospective Analysis. Pregnancy Hypertension, 12, 174-177. https://doi.org/10.1016/j.preghy.2017.11.007
[42]
(2019) ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 133, 1. https://doi.org/10.1097/AOG.0000000000003018
[43]
Dong, X., Gou, W., Li, C., Wu, M., Han, Z., Li, X., et al. (2017) Proteinuria in Preeclampsia: Not Essential to Diagnosis but Related to Disease Severity and Fetal Outcomes. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health, 8, 60-64. https://doi.org/10.1016/j.preghy.2017.03.005
[44]
Tanacan, A., Fadiloglu, E. and Beksac, M.S. (2019) The Importance of Proteinuria in Preeclampsia and Its Predictive Role in Maternal and Neonatal Outcomes. Hypertension in Pregnancy, 38, 111-118. https://doi.org/10.1080/10641955.2019.1590718
